SFC Issues Guidance on Disclosure and Complex Product Treatment for Funds with Private Market Exposu
Key Takeaways
- The Hong Kong SFC has issued a circular requiring management companies of SFC-authorized public funds with direct or indirect private credit or private equity exposure to adopt enhanced offering document disclosures.
- Funds with 50% or more of NAV in private market assets will be classified as complex products, and the SFC may also designate funds below that level.
- Compliance teams should begin reviewing existing funds now, as the SFC expects updates as soon as practicable.
Deep Dive
The circular applies to management companies of SFC-authorized funds offered to the public in Hong Kong, excluding listed closed-ended alternative asset funds (LAFs), which are covered by separate guidance. It covers direct exposure (loans or equities in unlisted companies) and indirect exposure through business development companies (BDCs), collateralized loan obligations (CLOs), and derivatives such as total return swaps (TRSs) and significant risk transfers (SRTs). The SFC lists these indirect examples as non-exhaustive and subject to future update. Direct exposure also remains subject to the 15% of NAV limit under UT Code 7.3.
The core requirements are enhanced disclosures in offering documents, including the key facts statement (KFS). Funds must disclose (i) the extent and means of access to exposure, (ii) the nature and characteristics of the underlying assets, such as minimum CLO credit ratings, and (iii) the key risks and their implications for the Fund and investors, including liquidity, valuation, and transparency concerns. Funds with aggregate direct and indirect exposure of 50% or more of NAV are complex products. The SFC may also designate funds below that threshold, using a holistic assessment of aggregate exposure, strategy, liquidity and risk profile, asset characteristics (such as CLO tranches and SRT structures), and home regulator restrictions. Complex product status triggers suitability obligations regardless of whether solicitation or recommendation occurs (Code of Conduct para. 5.5 and Chapter 6 of the Online Distribution and Advisory Platforms Guidelines).
The circular also reinforces existing obligations: target market identification, distributor selection and product risk rating under the 2014 (updated 2016) internal product approval guidance, and fair, balanced advertising with adequate risk disclosure under the Advertising Guidelines. For new applications, funds with private market exposure may face closer scrutiny and may be excluded from FASTrack processing, which could lengthen authorization timelines. No fixed deadline is set. Existing funds must be reviewed, offering documents updated "as soon as practicable," and distributors informed, so the SFC could evaluate promptness informally.
Recommended actions: (1) inventory all funds for direct and indirect private market exposure, including look-through on BDCs, CLOs, and derivatives; (2) calculate aggregate exposure against the 50% threshold and document the analysis for funds near or below it; (3) draft and file updated offering documents and KFS with specific, quantified disclosures; (4) reassess target market definitions and distributor suitability, and communicate complex product status and risk features to distributors; (5) review marketing materials for balance; (6) consult the SFC early on classification doubts; and (7) build pipeline planning that accounts for the loss of FASTrack. Failure to act risks regulatory scrutiny, mis-selling exposure, and reputational harm, particularly given the SFC's stated concern about rising private credit defaults and widening BDC price-to-NAV discounts.

